Mucoidy, quorum sensing, mismatch repair and antibiotic resistance in pseudomonas aeruginosa from cystic fibrosis chronic airways infections

PLoS ONE

Volumn 5, Issue 9, 2010, Pages 1-12

  Feliziani, Sofía ^a   Luján, Adela M ^a   Moyano, Alejandro J ^a   Sola, Claudia ^a   Bocco, José L ^a   Montanaro, Patricia ^b   Canigia, Liliana Fernández ^c   Argaraña, Carlos E ^a   Smania, Andrea M ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b Hospital de Niños Santísima Trinidad   (Argentina)

^c HOSPITAL ALEMÁN   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; RIFAMPICIN; TOBRAMYCIN; BACTERIAL PROTEIN; LASR PROTEIN, PSEUDOMONAS AERUGINOSA; MEXZ PROTEIN, PSEUDOMONAS AERUGINOSA; MUCA PROTEIN, BACTERIA; TRANSACTIVATOR PROTEIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; CONTROLLED STUDY; CYSTIC FIBROSIS; GENE FUNCTION; GENE INACTIVATION; GENE LOSS; GENE MUTATION; GENE SEQUENCE; GENETIC TRAIT; GENOTYPE; LASR GENE; LUNG FIBROSIS; MEXZ GENE; MISMATCH REPAIR; MRS GENE; MUCA GENE; MUTAGENESIS; MUTL GENE; MUTS GENE; NONHUMAN; PHENOTYPE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; QUORUM SENSING; RESPIRATORY TRACT INFECTION; ADOLESCENT; ADULT; CHILD; CHRONIC DISEASE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MALE; METABOLISM; MICROBIOLOGY; MUTATION; PHYSIOLOGY; PRESCHOOL CHILD; RESPIRATORY SYSTEM;

PSEUDOMONAS AERUGINOSA;

ADOLESCENT; ADULT; BACTERIAL PROTEINS; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CYSTIC FIBROSIS; DNA MISMATCH REPAIR; DRUG RESISTANCE, MICROBIAL; FEMALE; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; MALE; MUTATION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; QUORUM SENSING; RESPIRATORY SYSTEM; TRANS-ACTIVATORS; YOUNG ADULT;

EID: 77958595499     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012669     Document Type: Article

References (62)

1. Govan JR, Deretic V (1996) Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev 60: 539-574.
2. Lyczak JB, Cannon CL, Pier GB (2002) Lung infections associated with cystic fibrosis. Clin Microbiol Rev 15: 194-222.
3. Romling U, Wingender J, Muller H, Tummler B (1994) A major Pseudomonas aeruginosa clone common to patients and aquatic habitats. Appl Environ Microbiol 60: 1734-1738.
4. Martin C, Ichou MA, Massicot P, Goudeau A, Quentin R (1995) Genetic diversity of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis revealed by restriction fragment length polymorphism of the rRNA gene region. J Clin Microbiol 33: 1461-1466.
5. Nguyen D, Singh PK (2006) Evolving stealth: genetic adaptation of Pseudomonas aeruginosa during cystic fibrosis infections. Proc Natl Acad Sci U S A 103: 8305-8306.
6. Smith EE, Buckley DG, Wu Z, Saenphimmachak C, Hoffman LR, et al. (2006) Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients. Proc Natl Acad Sci U S A 103: 8487-8492.
7. Martin DW, Schurr MJ, Mudd MH, Govan JR, Holloway BW, et al. (1993) Mechanism of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients. Proc Natl Acad Sci U S A 90: 8377-8381.
8. Hancock RE, Mutharia LM, Chan L, Darveau RP, Speert DP, et al. (1983) Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains. Infect Immun 42: 170-177.
9. D'Argenio DA, Wu M, Hoffman LR, Kulasekara HD, Deziel E, et al. (2007) Growth phenotypes of Pseudomonas aeruginosa lasR mutants adapted to the airways of cystic fibrosis patients. Mol Microbiol 64: 512-533.
10. Hoffman LR, Kulasekara HD, Emerson J, Houston LS, Burns JL, et al. (2009) Pseudomonas aeruginosa lasR mutants are associated with cystic fibrosis lung disease progression. J Cyst Fibros 8: 66-70.
11. Luzar MA, Thomassen MJ, Montie TC (1985) Flagella and motility alterations in Pseudomonas aeruginosa strains from patients with cystic fibrosis: relationship to patient clinical condition. Infect Immun 50: 577-582.
12. Mahenthiralingam E, Campbell ME, Speert DP (1994) Nonmotility and phagocytic resistance of Pseudomonas aeruginosa isolates from chronically colonized patients with cystic fibrosis. Infect Immun 62: 596-605.
13. Barth AL, Pitt TL (1995) Auxotrophic variants of Pseudomonas aeruginosa are selected from prototrophic wild-type strains in respiratory infections in patients with cystic fibrosis. J Clin Microbiol 33: 37-40.
14. Gibson RL, Burns JL, Ramsey BW (2003) Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 168: 918-951.
15. Vogne C, Aires JR, Bailly C, Hocquet D, Ple ́siat P (2004) Role of the multidrug efflux system MexXY in the emergence of moderate resistance to aminoglyco-sides among Pseudomonas aeruginosa isolates from patients with cystic fibrosis. Antimicrob Agents Chemother 48: 1676-1680.
16. Ciofu O, Riis B, Pressler T, Poulsen HE, Høiby N (2005) Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation. Antimicrob Agents Chemother 49: 2276-2282.
17. Maciá MD, Blanquer D, Togores B, Sauleda J, Pe ́rez JL, et al. (2005) Hypermutation is a key factor in development of multiple-antimicrobial resistance in Pseudomonas aeruginosa strains causing chronic lung infections. Antimicrob Agents Chemother 49: 3382-3386.
18. Montanari S, Oliver A, Salerno P, Mena A, Bertoni G, et al. (2007) Biological cost of hypermutation in Pseudomonas aeruginosa strains from patients with cystic fibrosis. Microbiology 153: 1445-1454.
19. Oliver A, Cantón R, Campo P, Baquero F, Blázquez J (2000)High frequency of hypermutable Pseudomonas aeruginosa in cystic fibrosis lung infection. Science 288: 1251-1254.
20. Oliver A, Baquero F, Blázquez J (2002) The mismatch repair system (mutS, mutL and uvrD genes) in Pseudomonas aeruginosa: molecular characterization of naturally occurring mutants. Mol Microbiol 43: 1641-1650.
21. Hogardt M, Schubert S, Adler K, Gotzfried M, Heesemann J (2006) Sequence variability and functional analysis of MutS of hypermutable Pseudomonas aeruginosa cystic fibrosis isolates. Int J Med Microbiol 296: 313-320.
22. Mena A, Smith EE, Burns JL, Speert DP, Moskowitz SM, et al. (2008) Genetic adaptation of Pseudomonas aeruginosa to the airways of cystic fibrosis patients is catalyzed by hypermutation. J Bacteriol 190: 7910-7917.
23. Waine DJ, Honeybourne D, Smith EG, Whitehouse JL, Dowson CG (2008) Association between hypermutator phenotype, clinical variables, mucoid phenotype, and antimicrobial resistance in Pseudomonas aeruginosa. J Clin Microbiol 46: 3491-3493.
24. Kenna DT, Doherty CJ, Foweraker J, Macaskill L, Barcus VA, et al. (2007) Hypermutability in environmental Pseudomonas aeruginosa and in populations causing pulmonary infection in individuals with cystic fibrosis. Microbiology 153: 1852-1859.
25. Ferroni A, Guillemot D, Moumile K, Bernede C, Le Bourgeois M, et al. (2009) Effect of mutator P. aeruginosa on antibiotic resistance acquisition and respiratory function in cystic fibrosis. Pediatr Pulmonol 44: 820-825.
26. Henrichfreise B, Wiegand I, Pfister W, Wiedemann B (2007) Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation. Antimicrob Agents Chemother 51: 4062-4070.
27. Oliver A, Levin BR, Juan C, Baquero F, Blázquez J (2004) Hypermutation and the preexistence of antibiotic-resistant Pseudomonas aeruginosa mutants: implications for susceptibility testing and treatment of chronic infections. Antimicrob Agents Chemother 48: 4226-4233.
28. Plasencia V, Borrell N, Maciá MD, Moya B, Pe ́rez JL, et al. (2007) Influence of high mutation rates on the mechanisms and dynamics of in vitro and in vivo resistance development to single or combined antipseudomonal agents. Antimicrob Agents Chemother 51: 2574-2581.
29. Gutierrez O, Juan C, Pe ́rez JL, Oliver A (2004) Lack of association between hypermutation and antibiotic resistance development in Pseudomonas aeruginosa isolates from intensive care unit patients. Antimicrob Agents Chemother 48: 3573-3575.
30. Moyano AJ, Luján AM, Argarana CE, Smania AM (2007) MutS deficiency and activity of the error-prone DNA polymerase IV are crucial for determining mucA as the main target for mucoid conversion in Pseudomonas aeruginosa. Mol Microbiol 64: 547-559.
31. Luján AM, Moyano AJ, Segura I, Argaran ̃a CE, Smania AM (2007) Quorum- sensing-deficient (lasR) mutants emerge at high frequency from a Pseudomonas aeruginosa mutS strain. Microbiology 153: 225-237.
32. Smania AM, Segura I, Pezza RJ, Becerra C, Albesa I, et al. (2004) Emergence of phenotypic variants upon mismatch repair disruption in Pseudomonas aeruginosa. Microbiology 150: 1327-1338.
33. Garibyan L, Huang T, Kim M, Wolff E, Nguyen A, et al. (2003) Use of the rpoB gene to determine the specificity of base substitution mutations on the Escherichia coli chromosome. DNA Repair (Amst) 2: 593-608.
34. LeClerc JE, Li B, Payne WL, Cebula TA (1996) High mutation frequencies among Escherichia coli and Salmonella pathogens. Science 274: 1208-1211.
35. Obmolova G, Ban C, Hsieh P, Yang W (2000) Crystal structures of mismatch repair protein MutS and its complex with a substrate DNA. Nature 407: 703-710.
36. Pezza RJ, Villarreal MA, Montich GG, Argaran ̃a CE (2002) Vanadateinhibits the ATPase activity and DNA binding capability of bacterial MutS. A structural model for the vanadate-MutS interaction at the Walker A motif. Nucleic Acids Res 30: 4700-4708.
37. Boucher JC, Yu H, Mudd MH, Deretic V (1997) Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection. Infect Immun 65: 3838-3846.
38. Ciofu O, Lee B, Johannesson M, Hermansen NO, Meyer P, et al. (2008) Investigation of the algT operon sequence in mucoid and non-mucoid Pseudomonas aeruginosa isolates from 115 Scandinavian patients with cystic fibrosis and in 88 in vitro non-mucoid revertants. Microbiology 154: 103-113.
39. Levy DD, Cebula TA (2001) Fidelity of replication of repetitive DNA in mutS and repair proficient Escherichia coli. Mutat Res 474: 1-14.
40. Shaver AC, Dombrowski PG, Sweeney JY, Treis T, Zappala RM, et al. (2002) Fitness evolution and the rise of mutator alleles in experimental Escherichia coli populations. Genetics 162: 557-566.
41. Taddei F, Matic I, Godelle B, Radman M (1997) To be a mutator, or how pathogenic and commensal bacteria can evolve rapidly. Trends Microbiol 5: 427-428; discussion 428-429.
42. Taddei F, Radman M, Maynard-Smith J, Toupance B, Gouyon PH, et al. (1997) Role of mutator alleles in adaptive evolution. Nature 387: 700-702.
43. Maciá MD, Borrell N, Pe ́rez JL, Oliver A (2004) Detection and susceptibility testing of hypermutable Pseudomonas aeruginosa strains with the Etest and disk diffusion. Antimicrob Agents Chemother 48: 2665-2672.
44. Govan JR, Fyfe JA (1978) Mucoid Pseudomonas aeruginosa and cystic fibrosis: resistance of the mucoid from to carbenicillin, flucloxacillin and tobramycin and the isolation of mucoid variants in vitro. J Antimicrob Chemother 4: 233-240.
45. Hoffman LR, Richardson AR, Houston LS, Kulasekara HD, Martens-Habbena W, et al. (2010) Nutrient availability as a mechanism for selection of antibiotic tolerant Pseudomonas aeruginosa within the CF airway. PLoS Pathog 6: e1000712.
46. Mandsberg LF, Ciofu O, Kirkby N, Christiansen LE, Poulsen HE, et al. (2009) Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system. Antimicrob Agents Chemother 53: 2483-2491.
47. Hogardt M, Hoboth C, Schmoldt S, Henke C, Bader L, et al. (2007) Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis. J Infect Dis 195: 70-80.
48. Sobel ML, McKay GA, Poole K (2003) Contribution of the MexXY multidrug transporter to aminoglycoside resistance in Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother 47: 3202-3207.
49. Westbrock-Wadman S, Sherman DR, Hickey MJ, Coulter SN, Zhu YQ, et al. (1999) Characterization of a Pseudomonas aeruginosa efflux pump contributing to aminoglycoside impermeability. Antimicrob Agents Chemother 43: 2975-2983.
50. Schaaper RM, Dunn RL (1987) Spectra of spontaneous mutations in Escherichia coli strains defective in mismatch correction: the nature of in vivo DNA replication errors. Proc Natl Acad Sci U S A 84: 6220-6224.
51. Sanders LH, Rockel A, Lu H, Wozniak DJ, Sutton MD (2006) Role of Pseudomonas aeruginosa dinB-encoded DNA polymerase IV in mutagenesis. J Bacteriol 188: 8573-8585.
52. Moyano AJ, Smania AM (2009) Simple sequence repeats and mucoid conversion: biased mucA mutagenesis in mismatch repair-deficient Pseudomonas aeruginosa. PLoS One 4: e8203.
53. Ciofu O, Mandsberg LF, Bjarnsholt T, Wassermann T, Høiby N (2010) Genetic adaptation of Pseudomonas aeruginosa during chronic lung infection of patients with cystic fibrosis: strong and weak mutators with heterogeneous genetic back-grounds emerge in mucA and/or lasR mutants. Microbiology 156: 1108-1119.
54. Romling U, Tummler B (2000) Achieving 100% typeability of Pseudomonas aeruginosa by pulsed-field gel electrophoresis. J Clin Microbiol 38: 464-465.
55. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, et al. (1995) Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 33: 2233-2239.
56. Pezza RJ, Smania AM, Barra JL, Argaran ̃a CE (2002) Nucleotides and heteroduplex DNA preserve the active conformation of Pseudomonas aeruginosa MutS by preventing protein oligomerization. Biochem J 361: 87-95.
57. Ng PC, Henikoff S (2003) SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res 31: 3812-3814.
58. Kovach ME, Elzer PH, Hill DS, Robertson GT, Farris MA, et al. (1995) Four new derivatives of the broad-host-range cloning vector pBBR1MCS, carrying different antibiotic-resistance cassettes. Gene 166: 175-176.
59. Choi KH, Kumar A, Schweizer HP (2006) A 10-min method for preparation of highly electrocompetent Pseudomonas aeruginosa cells: application for DNA fragment transfer between chromosomes and plasmid transformation. J Microbiol Methods 64: 391-397.
60. Holloway BW (1955) Genetic recombination in Pseudomonas aeruginosa. J Gen Microbiol 13: 572-581.
61. Jacobs MA, Alwood A, Thaipisuttikul I, Spencer D, Haugen E, et al. (2003) Comprehensive transposon mutant library of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A 100: 14339-14344.
62. Jacquelín DK, Filiberti A, Argaraña CE, Barra JL (2005) Pseudomonas aeruginosa MutL protein functions in Escherichia coli. Biochem J 388: 879-887.